Events

BIO 2009, Atlanta, May 18-21, 2009

Learn more about ri:val and its application at Avance's booth at the BIO 2009 in Atlanta.

BioPartnering, Vancouver, February 9-10, 2009

Learn more about ri:val and its application and meet Avance at the North American BioParnering meeting in Vancouver.

New Releases

September 2008: Release of ri:val v3.0

• Multi-indication projects
• Commercial milestones
• Co-development, co-promotion, profit sharing
• Cross royalties
• "Early royalty scheme"

August 2008: Release of ri:val v2.7

• Non-life science projects
• NPV valuations in addition to rNPV and real options

June 2008: Release of ri:val v2.6

• Negotiation tool

March 2008: Release of ri:val v2.5

• Portfolio module
• Sensitivity analysis
  

February 2008: Release of ri:val v2.4

• Export of calculations into Excel

December 2007: Release of ri:val v2.3

• Advanced sales curve modelling
• Absolute and relative sales input
• Optional phase 2a/2b split
• 5 royalty tiers
• Royalties after patent expiry
• Three way licensing agreements
• License contract value development
• 2006 drug development data